Skip to main content

Thalassemia in Refugee Patients

2 ደቒቕ ንባብ|May 13, 2026||ሓርሓር ምልክት

Overview

Thalassemia variants are common in refugees from Africa, the Mediterranean, and Asia. They are detected on routine hemoglobinopathy screening.

Important: Always wait for the complete hemoglobinopathy screen before interpreting MCV. Thalassemia trait causes microcytosis even without iron deficiency.

 

Alpha-Thalassemia

Caused by deletions in 1-4 of the alpha globin genes.

Genotype

Missing Genes

Clinical Effect

Management

Silent carrier

1

Asymptomatic, normal CBC

No treatment. Genetic counselling if planning pregnancy.

Alpha-thal trait

2

Mild anemia, microcytosis

No treatment. Genetic counselling if planning pregnancy.

Hemoglobin H disease

3

Moderate to severe anemia

Refer to Hematology. Folic acid 1-2 mg daily. Avoid iron supplements unless iron deficient.

Hydrops fetalis

4

Incompatible with life

Genetic counselling essential pre-pregnancy

 

If a patient has any alpha-thal allele and is planning a pregnancy: test the partner. If there is risk of Hb H disease or hydrops fetalis in the fetus, refer to Medical Genetics.

 

Beta-Thalassemia

Caused by mutations reducing or eliminating beta globin expression.

Type

Clinical Effect

Management

Beta-thal minor

Mild anemia, marked microcytosis

No treatment. Usually asymptomatic.

Beta-thal intermedia

Moderate anemia, may need transfusions

Refer to Hematology

Beta-thal major

Severe transfusion-dependent anemia

Refer to Hematology. Usually already diagnosed.

 

If a patient has any beta-thal allele and is planning a pregnancy: test the partner. If there is risk of beta-thal major or intermedia in the fetus, refer to Medical Genetics.


 

ኣካፍሉ:
initial-health-assessmentrefugeesphase-initial-resettlementclinical-guidelineadultslang-en
እዚ ገጽ ረድእ ነይሩ?